Who we are

Cipla Quality Chemical Industries Limited (CiplaQCIL) is a state of the art pharmaceutical plant that manufactures the latest Anti-retroviral (ARVs), Anti-malarial (ACTs) and Hepatitis medicines.

Vision

To become a center of excellence in the manufacturing of quality, affordable and newer medicines.

Mission

To sustainably avail affordable and efficacious medicines in order to improve the quantity and quality of life.

Values

Quality & Excellence, Accountability, Teamwork, Integrity, Customer focus, Innovation

Standards

  • The plant has been designed to meet the world’s most stringent regulatory standards.
  • The goal of the design specifications for CiplaQCIL is to produce pharmaceutical products of the highest quality that have zero environmental impact, adhere to current Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP), all consistent with global, regional and local regulatory standards.

Regulatory Approvals


DNDI


DNME-Angola


DPM-Ivory Coast


WHO


FDA Ghana


FMHCA Ethiopia


ICRC


ZAMRA-Zambia


KPPB Kenya


Mozambique


NDA Uganda


TFDA-Tanzania


NMRC Namibia


PMPB Malawi


RBC Rwanda


SSGMC-South-Sudan